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ABSTRACT
Diabetic patients' numbers are increasing around the world, this metabolic disease affects patient's quality of life in all domains: physically, socially, psychologically and emotionally. As the
disease progresses patients need to use insulin. According to the Palestinian MOH (Ministry of
Health) 12% of people in Palestine have diabetes. Twenty percent of type 2 diabetic patients visit
the MOH clinics and use insulin also 12% use both insulin and oral drugs to control their blood
glucose levels. These patients administer insulin subcutaneously by vial and syringe. The aim of
this study was to assess QoL (quality of life) of diabetic patients using insulin, factors affecting it,
preference of patients to use insulin pen and their willingness to pay for them. Method: A descriptive study conducted with a sample of 311 diabetic patients that use vial/syringe to administer insulin and attending MOH diabetic clinics in Bethlehem and Hebron. A questionnaire was designed to
assess four parts; socio-demographic part, patient's health profile, QoL part and willingness to pay
for insulin pens part. QoL was measured using SF-36v2® questionnaire and the willingness to pay
part validated using pilot study. Results were analyzed using Quality Metric Health Outcomes™
Scoring Software 4.0 and SPSS software. Results and conclusion: The mean scores of QoL domains ranged from 40.7 to 65.6. Diabetic patients had lower scores than general population in all
domains of QoL; physical functioning, role-physical, body pain, general health, vitality, roleemotional, mental health, physical composite summary and mental composite summary, except in
social functioning. The majority of participants had lower scores than general population in all QoL
domains. The results revealed that gender, age and glycemic control, number of family members,
duration of insulin use had no significant impact on QoL. Approximately 77% of participants reported having complications, which had a significant negative effect on their QoL (P-value < 0.001
in all domains). Single patients and patients living in Hebron had a significant positive effect on
QoL. Higher level of education, high monthly income and being employed had a positive effect on
QoL while longer duration of diabetes had negative effect. Eighty-five percent of participants preferred to use insulin pens if it was available as a choice in the MOH; 35% of them were willing to
pay extra money to get insulin pens instead of vial/syringe. This study revealed that the QoL of
diabetic patients using insulin in this sample was low, which could be increased if the government
included insulin pens in the MOH drug list.
KEYWORDS: Quality of life; Diabetes mellitus; Willingness to pay.
INTRODUCTION
The number of diabetic patients is increasing around the world. It was estimated
using 133 studies from 91 countries that the
number of diabetic patients will increase
from 2010 to 2030 by 54%, the number in
developing countries was expected to increase by 69%, while in developed countries
by 20% [1].
In the Palestinian West Bank the prevalence of diabetes was 15.3% in 2010 and is
expected to increase to 23.4% by 2030 [2].

According to the Palestinian MOH (Ministry
of Health) the number of deaths caused by
diabetes complications was 869 in 2015,
which is estimated to be 19.7 out of 100.000
[3].
With the increase in number of people
with diabetes, caring for those patients is
considered a global challenge. They make a
huge effort and many decisions every day
and all day long to reach a non-diabetic metabolism rate, which will affect social, physical and emotional aspects of life. So, the
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evaluation of QoL (Quality of Life) in these
patients is essential to measure psychosocial
well-being, the benefits of new treatments
and to identify the dissatisfaction of the existing treatments.
Quality of life was defined by the WHO
(World Health Organization) in 1947 as the
perception of the individual's position in life,
including the person's satisfaction of physical
health, psychological health and social relationships [4, 5]. Quality of life defined also
as the personal evaluation of how good or
bad their life is. It evaluates the satisfaction
of person's life in many aspects including
psychological, environmental, social and
physical. HRQoL (Health related Quality of
Life) concerns of health aspects as well as
general QoL; it is the patient's perception of
the effect of illness or treatments on their
QoL, these two concepts, QoL and HRQoL,
are used interchangeable [5].
Many studies indicated that QoL was
lower in diabetic patients than other population [6]. In Gaza diabetic patients had lower
scores than non-diabetics in all QoL domains; physical, psychological, environmental and social relationships [7]. In North West
Bank a recent study found that 30% of type 2
diabetic patients had poor general health and
moderate pain [8], while within type 1 diabetic patients a recent study showed that the
mean score of QoL ranged from 51.7% to
75.6%, the highest scores were in the bodily
pain domain and the lowest in general health
domain. Those results were lower than QoL
of type 1 diabetes in other populations [9].
Diabetic Patients from two clinics, Al-Watani
Hospital and Al-Makhfyah primary health
care clinic in Nablus were studies it was
found that older age being unemployed and
the presence of comorbidities were associated
with lower QoL. On the other hand treatment
satisfaction was not associated with HRQoL
[10].
Studies have found that the presence of
complications have a negative effect on QoL
of diabetic patients [11-13]. Quality of life
was also found to be affected by many factors; HbA1c levels, number of insulin injections, type of diabetes, duration of diabetes,
monthly income and age [6, 7, 9, 12, 14-17].
In order to achieve glycemic control
multiple daily injections of insulin are rec-

ommended for patients. Many patients treated with insulin fear the needles, lack sufficient diabetes education and deny the need
for insulin, all these reasons contribute to the
non-adherence in those patients [18, 19].
Many studies have also found that the QoL of
diabetic patients can be improved by the use
of insulin pens for insulin delivery [20, 21].
Many studies assessed the preference of
patients to use insulin pens over syringe/vial
and found that most patients preferred the use
of insulin pens when they had used both [13,
22, 23].
The aim of our study was to describe the
QoL of diabetic patients that use insulin in
the MOH clinics in Bethlehem and Hebron
and to identify important variables that affect
QoL for these patients. The secondary aim
was to assess the preference of diabetic patients for insulin pens and the amount of
money they are willing to pay for them.
METHODS
Study population
This was a cross sectional study among
diabetic patients that use insulin in Bethlehem and Hebron MOH clinics. The target
population for this study was diabetic patients that use insulin by vial/syringe and attend the MOH clinics in Bethlehem and Hebron. Ethical Approval for this study was obtained from Palestinian Ministry of Health
(Reference number 1035/56 3/10/2016). Ministry of health facilities have purposely chosen based on the high percentage of diabetic
patients attending these health care facilities.
Inclusion criteria for patients were: Diabetic
patients using insulin by vial/syringe, diagnosed with type 1 or 2 diabetes and being 17
years old and more (both male and female).
Exclusion criteria were patients who did not
agree to participate; patients use only oral
hypoglycemic drugs and patients using insulin pens during the time of the study. 30 patients were recruited to perform a pilot study
of the WTP (willingness to pay) domain in
order to test if it was appropriate and clear for
the patients.
Our sample was 311 patients. All eligible patients were approached as they came in
for routine follow-ups during the data collection period in the primary health clinics. Patients who met the study inclusion criteria
were asked if they were willing to participate
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in the study by completing the questionnaire
while they were waiting to see the doctor.
Verbal consent was obtained from each patient prior to completing the questionnaire.
The interview with participants needed from
15 to 20 minutes.
Questionnaire
In our study, we used a questionnaire of
four parts; socio-demographic, health profile,
quality of life and willingness to pay. The
socio-demographic information sheet covered
the following areas of interest: Gender, age,
educational level, occupation, marital status,
residency and income status. Health profile
part included duration of diabetes, duration of
insulin use, type of diabetes, HbA1c (glycated hemoglobin) level, type of treatment,
incidence of hypoglycemia, insulin dosage
regimen and presence of complications.
The Palestinian version of SF-36v2®
Health Survey was used to assess quality of
life for diabetic patients using insulin. The
Non-Commercial License Agreement was
obtained from OptumInsight Life Sciences
incorporation (OPTUM). SF-36v2 is a valid
survey that has been used in many studies.
The certificate of Arabic (for Palestine) of the
SF-36v2® Health Survey was obtained from
the OPTUM incorporation. We used the eight
domains measured by SF-36; physical functioning (PF), role physical (RP) which is role
limitation due to physical health issues, bodily pain (BP), general health (GH), vitality
and energy (VT), social functioning (SF),
role emotional (RE) that is role limitation due
to emotional problems and mental health
(MH) to assess quality of life. Also the two
summary components were used that are 1physical component summary (PCS), which
represents physical limitations, disabilities
and the presence of fatigue and body pain. 2The mental component summary (MCS),
which evaluates psychological distress and
limitations due to emotional problems. The
scoring range of the eight scales ranges is
from 0 to 100, higher scores indicates a better
quality of life.
WTP survey was used in this study to
examine the patient's preference for the insulin pens and their willingness to pay for those
pens.

Data analysis
The questionnaires were filled and the
data for QoL part were introduced in the
Quality Metric Health Outcomes™ Scoring
Software 4.0. The results were in a scale of 0
to 100. These results from the software were
introduced into the SPSS program. A oneway Analysis of Variance (ANOVA) was
used to compare differences between subgroups of independent categorical variables.
Post-hoc analyses (Scheffé’s Post hoc Test)
was then conducted to test for differences
between the groups to determine if the overall ANOVA was statistically significant. For
interpretation of the results, P <0.05 was
considered to be statistically significant. Confidence intervals were calculated at the 95%
level of confidence. Multiple regression
analysis was used to test which variables significantly predicted PCS and MCS.
RESULTS
Socio-economic and health profile
The sample used was 311 patients distributed
as 114 patients in Bethlehem and 196 patients
in Hebron Socio-economic information
summary of the sample is presented in Table
1.
Table )1): distribution of the participants by
socio-demographic characteristics.
Variable
17-40
41-59
>60
Female
Gender
Male
Married
Widow
Marital
status
Single
Divorced
No
schooling
Elementary and
Education secondary
level
school
Diploma
Professional
Full timejob
Employment sta- Part timetus
job
No work
Age, years

Frequency
78
120
110
162
149
264
21
25
1
110

Percent
25.3%
38.9%
35.7%
52.1%
47.9%
84.9%
6.8%
8.0%
0.3%
35.%

160
51.%
15
26

4.8%

47

15.%

17

5.5%

246

79.%

8.4%
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Most subjects 269 patients (86.5%) had
type 2 diabetes and 42 (13.5%) had type 1.
Almost 50% (169) of the subjects reported
that they had hypoglycemia in the past four
weeks. When patients were asked about their
insulin regimen, 210 (67.5%) of participants
reported they used insulin two times daily, 71
(22.8%) three times and 30 (9.6%) once daily. The mean level of HbA1c was 9% with a
standard deviation of 2. The majority of patients (97%) (254 patients) had HbA1c level
of 7 and higher while only 3% (8 patients)
had HbA1c level of less than 7.

(58%, 180 patients), followed by neurological disorders (42%, 51 patients), heart disease
(31%, 97 patients), stroke (22%, 67 patients),
renal complications (16%, 51 patients) and
foot ulcers (14%, 42 patients). The least
common complication was gangrene. On the
other hand, 70 patients (23%) reported they
had no complications of diabetes.
QoL scores

The mean scores of the quality of life
domains are shown in table 2. The domain
with the highest score was social functioning
(M = 65.6, ±SD 36.2), followed by physical
The duration of diabetes ranged from
functioning (M= 58.91, ±SD 31.2) and role
less than a year to 59 years with a mean of
emotional (M = 58.91, ±SD 34.58). The low14.9 years (±SD 13.6). The average duration
est was vitality (M = 40.7, ±SD). The mean
of using insulin was 6.6 years. Sixty-seven
score for physical component summary was
(21.6%) of patients reported they had one
lower than mental component summary. The
complication, 74 (23.8%) reported two compercentage of patients that had scores above
plications and 98 (31.4%) reported from 3 to
the general population norms appears rela7 complications. The most frequent complitively low for all domains (ranging from 12%
cation between patients was visual disorders
to 30%).
Table (2): Mean scores of participants' quality of life domains, standard deviation and percentages
of participants whose scores were above or below the general population norm.
Domains
PCS (Physical Component Summary)
(PCS)
PF (Physical Functioning)
RP (Role Physical)
BP (Bodily Pain)
GH (General Health)
MCS (Mental Component Summary)
VT (Vitality)
SF (Social Functioning)
RE (Role Emotional)
MH (Mental Health)

Above the general population
norms* (%)

Below the general population
norms (%)

11.67

17

63

31.2
36.72
32.64
22.0
12.19
27.01
36.23
34.59
24.33

19
17
21
12
15
18
43
30
16

56
68
60
58
59
59
45
60
62

Mean

SD

41.42
58.92
44.25
49.03
48.3
41.32
40.73
65.61
58.91
54.25

* U.S general population norms.
Factors affecting QoL
There was no significant relationship between gender and QoL domains except for
body pain in which men had a higher score
than women. Age also didn't affect QoL domains. The mean score of all domains was
higher for patients in Bethlehem relative to
Hebron (3 points difference in MCS and PCS
between patients in Bethlehem and Hebron,
p-value < 0.05). Single patients had higher

scores in all domains compared to married
and widow (13 points difference in PCS, pvalue < 0.001). Participants who were illiterate had lower mean scores in all domains
than those who had primary or secondary
education, diploma and university level of
education (12 points difference in PCS and 7
points in MCS between patients that are illiterate and who have a university degree, pvalue < 0.05). There was a significant positive relationship between working and QoL
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(8 points difference in PCS between patients
that have a full-time job and who are unemployed, p-value 0.000). On the other hand,
there was no significant relationship between
the place of living; village, city or camp and
QoL domains, QOL was not also affected by
the number of family members. Participants
with higher income had a higher mean QoL
scores (14-20 points difference in PF, SF and
RE, p< 0.05).
The mean scores for PF, RP, BP and
PCS QoL domains were lower in patients
who had been diagnosed with diabetes for
longer duration. The differences between patients had diabetes for less than 6 years and
who had it for more than 10 years were: 16
points in PF, 16 points in RP, 11 points in BP
and 7 points in PCS (p-value < 0.05), the
worst values were reached after 10 years. The
duration of using insulin didn't affect QoL
scores. The mean scores for all QoL domains
except MH, MCS and RE, were significantly
higher for type 2 diabetes patients than type 1
(p-value < 0.05). There was no significant
relationship between QoL and HbA1c levels.
The only domain that was significantly affected by the insulin regimen was GH with a
5 points difference between once and three
times regimen. The mean scores for all QoL
domains were significantly higher for patients with lower number of complications
(15 points in PCS and 13 points in MCS difference between patients had no complications and who had more than 4 complications, p-value<0.001).
Multiple regression analysis was used to
test which variables significantly predicted
PCS. The results indicated that the type of
diabetes, duration of diabetes, level of education and employment were significant predictors of PCS (p-value < 0.05). These four predictors explained 26.9% of the variance in
PCS; type of diabetes caused 14.2% of the
variance followed by duration of diabetes
(5.8%), level of education (4.7%) and employment (2.2%). On the other hand, MCS
was significantly predicted by level of education.
Willingness to Pay

will choose syringes. 130 (41.8%) of participants didn’t answer the question if they are
willing to pay more for the pens, 110 (35.4%)
reported they will and 71 (23%) reported that
they will not pay more.
As shown in table 3, the most common
two reasons reported by participants for
choosing pens were that they are easier to use
and inject than syringes. On the other hand,
the majority of patients 166 (92%), who
chose vial/syringe reported that they chose
vials because they are used to them.
Table (3): Reasons reported by patients for
choosing pens and syringes.
Reasons
Easier to use

What was
important to
you when
you chose
pens?

What was
important to
you when
you chose
vial/syringe

Easier to inject
More accurate in
measuring the
dose.
Need less time
for the injection
Causes less pain
More lifestyle
and social life
flexibility
Reading the dose
is easier
used to it
Less cost
Hard to learn to
use pens
Easy to use vials
Easy to inject by
syringe
Feel more confident about the
dose accuracy
Less painful
Syringes don’t
interfere with
daily activities
Easy to read the
dose
Believe to be
more able to control blood sugar

% of patients
92%
87%
66%
70%
65%
82%
79%
92%
72%
34%
81%
73%
64%
34%
69%
77%
77%

181 of subjects (58.2%) reported that if
both choices pens and syringes were available they will choose pens and 130 (41.8%)
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DISCUSSION
The results of this study agrees with a
previous study assessed QoL of type 2 diabetics in North West Bank [8]. They are also
consistent with other studies examined QoL
in diabetic patients and found that diabetes
mellitus affected health-related quality of life
of the participants [6, 24]. When compared to
a study in New Delhi, all domains except
general health were lower in our study [25].
Also, compared to a recent study in Saudi
Arabia, the scores of QoL were lower in all
domains except social functioning compared
to the Saudi patients' scores [26].
We found no significant relationship between glucose control (HbA1c levels) and
QoL, which was consistent with most studies
that found no relationship between glucose
control and QoL [27, 28]. Complications had
a very clear negative significant effect on all
QoL domains, many other studies showed a
negative impact of complications on QoL [7,
12, 13]. This study found that the mean
scores of QoL domains were higher for type
2 than type 1 diabetes, which is consistent
with other studies [15], The differences between the two types could be due to the differences in age and treatment regimens [28].
In all QoL domains, patients with a monthly
income more than $880 scored better than
patients with income less than $880 this was
consistent with a study that found that diabetic patients who had more than $530 monthly
income had better QoL than who have no
regular income [7]. There was no significant
relationship between gender and QoL except
in BP domain, this result is consistent with
other studies that assessed the QoL of diabetic patients in Gaza [7]. In this study, it was
found that better education was linked to better QoL in all domains, which agreed with
another study assessed QoL of diabetic patients using SF-20 [6]. Being employed was
also associated with better QoL in all domains, this result agrees with the findings of
Eljedi et.al [7] in Gaza and with other studies
[14]. These results could be due to the possibility that educated people have better selfesteem, better opportunity for employment,
higher income and better social life.

lin, these results are consistent with previous
studies that assessed the preference of patients for insulin pens and more than 70% of
patients preferred to use pens [22, 23]. Patients were not willing to make a substantial
out-of-pocket payment might be because diabetic patients registered in the MOH clinics
are used to pay only a co-payment out of
pocket for the prescription each month.
Several limitations of this study should
be considered when these results are interpreted. The sample is collected from Hebron
and Bethlehem so the results cannot be generalized to the Palestinian population. The
patients are studied once, and the effect of
using insulin pens is not studied. There is no
controlled group of patients using insulin
pens.
CONCLUSIONS
The majority of participants had lower
QoL than the general population norms and
the scores of all domains except the physical
and social functioning were below 50, which
indicated a low QoL. QoL of Diabetic patients using insulin was influenced by residency, marital status, level of education, employment, monthly income, diabetes duration, diabetes type, diabetes complications
and insulin regimen. Most patients (58%)
preferred to use pens if it was available as a
choice for insulin administration. The number of diabetic patients in Palestine is increasing. One of the main objectives of diabetes
treatment program is to promote the QoL of
diabetic patients. A close look at the health
care system is needed in order to try to improve QoL by possible introduction of insulin
pens as a choice for diabetic patients using
insulin. The introduction of insulin pens will
make insulin self-administration easier and
will decrease the discomfort of injection,
which could increase the QoL, compliance
and diabetes complications in the future and
eventually reduce the overall health care
costs.
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